Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors. Mol Cancer Ther. 2011 Mar; 10(3):558-65.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Class I Phosphatidylinositol 3-Kinases
Female
Humans
Male
Middle Aged
Mutation
Neoplasms
Phosphatidylinositol 3-Kinases
Polymerase Chain Reaction
Proto-Oncogene Proteins
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins p21(ras)
ras Proteins
TOR Serine-Threonine Kinases
Treatment Outcome
authors with profiles
John Moroney